Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 725-725
Open Access | Times Cited: 12
CD4+ T cells in antitumor immunity
Elena Montauti, David Y. Oh, Lawrence Fong
Trends in cancer (2024)
Open Access | Times Cited: 12
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Xiaoxia Chi, Shahang Luo, Peng Ye, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging
Xiaopan Ma, Xin Zhou, Biao Hu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 13, pp. 3838-3850
Closed Access | Times Cited: 21
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT
Hajime Senjo, Shinpei Harada, Shimpei I. Kubota, et al.
Blood (2023) Vol. 142, Iss. 5, pp. 477-492
Closed Access | Times Cited: 19
Landscape of Exhausted T Cells in Tuberculosis Revealed by Single-Cell Sequencing
Jiahui Pan, Xinyue Zhang, Jianting Xu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 14
Progress of research on PD-1/PD-L1 in leukemia
Huizhen Cao, Tianyu Wu, Xue Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques
Dabao He, Hengfeng Tang, Yang Xiaoling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Co-expression of B7-H3 and LAG3 represents cytotoxicity of CD4+ T cells in humans
Yumi Tamura, Shun Ohki, H NAGAI, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy
Dingkang Liu, Lichen Bao, Haichao Zhu, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 606-614
Closed Access | Times Cited: 10
Anti‐PD‐L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy‐refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study
Tao Ning, Danyang Li, Ting Deng, et al.
Cancer (2024) Vol. 130, Iss. 18, pp. 3137-3146
Open Access | Times Cited: 3
CD19-targeted HSP90 inhibitor nanoparticle combined with TKIs reduces tumor burden and enhances T-cell immunity in murine B-cell malignancies
Mengting Qin, Jianhua Ren, Xiaodong Chen, et al.
Theranostics (2025) Vol. 15, Iss. 8, pp. 3589-3609
Open Access
Harnessing the Transcriptional Signatures of CAR-T-Cells and Leukemia/Lymphoma Using Single-Cell Sequencing Technologies
Yu‐Mei Liao, Shih‐Hsien Hsu, Shyh‐Shin Chiou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2416-2416
Open Access | Times Cited: 3
Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress
Adel Chergui, John L. Reagan
Cancers (2023) Vol. 15, Iss. 16, pp. 4137-4137
Open Access | Times Cited: 7
Cytotoxic CD4 T cells in the mucosa and in cancer
Hrishi Venkatesh, Sean Tracy, Michael A. Farrar
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The intricate dance of tumor evolution: Exploring immune escape, tumor migration, drug resistance, and treatment strategies
Xiaojun Guo, Xiaonan Bian, Yitong Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 4, pp. 167098-167098
Closed Access | Times Cited: 2
A novel costimulatory molecule gene-modified leukemia cell-derived exosome enhances the anti-leukemia efficacy of DC vaccine in mouse models
Difan Zhang, Yan Jiang, Minghui Wang, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126097-126097
Closed Access | Times Cited: 2
Checkpoint inhibition in hematologic malignancies
Aaron Tsumura, Daniel J. Levis, Joseph M. Tuscano
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Integrative alternative splicing analysis reveals new prognosis signature in B-cell acute lymphoblastic leukemia
Zhiyi Zhuo, Junfei Wang, Yonglei Zhang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 11, pp. 4496-4512
Open Access | Times Cited: 1
Euphorbia helioscopia L. inhibits lung tumorigenesis through alleviating exhausted T cell induced by chronic inflammation
Wenbin Duan, Ziye Zhou, Yuqing Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119097-119097
Closed Access | Times Cited: 1
Harnessing the Transcriptional Signatures of Car-T Cells and Leukemia/Lymphoma Using Single-Cell Sequencing Technologies
Yu‐Mei Liao, Shih‐Hsien Hsu, Shyh‐Shin Chiou
(2024)
Open Access | Times Cited: 1
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases
Hanna Thorsson, Rasmus Henningsson, Noelia Puente‐Moncada, et al.
Blood (2024) Vol. 144, Iss. 13, pp. 1399-1411
Open Access | Times Cited: 1
AARS2 as a novel biomarker for prognosis and its molecular characterization in pan‐cancer
Long Liu, Jie Gao, Xudong Liu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 23, pp. 21531-21544
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top